Glucocorticoids activate Epstein Barr virus lytic replication through the upregulation of immediate early BZLF1 gene expression
- PMID: 20466055
- PMCID: PMC2939213
- DOI: 10.1016/j.bbi.2010.04.013
Glucocorticoids activate Epstein Barr virus lytic replication through the upregulation of immediate early BZLF1 gene expression
Abstract
Psychological stress-associated immune dysregulation has been shown to disrupt the steady-state expression and reactivate latent herpes viruses. One such virus is the Epstein Barr virus (EBV), which is associated with several human malignancies. EBV infects >90% of people living in North America and persists for life in latently infected cells. Although several studies have shown that glucocorticoids (GCs) can directly induce reactivation of the latent virus, the mechanism of stress hormone involvement in the control of EBV gene expression is not well understood. In this study, we tested the hypothesis that GCs can induce the latent EBV genome to lytically replicate through the induction of the EBV immediate early gene BZLF1 which encodes the lytic transactivator protein ZEBRA. We show a dose-dependent upregulation of BZLF1 mRNA expression by hydrocortisone (HC) and dexamethasone (Dex) in Daudi cells, an EBV genome positive Burkitt's lymphoma cell line, and Dex-induction of the early gene products BLLF3 (encoding for the EBV dUTPase) and BALF5 (encoding for the EBV DNA polymerase). We show that Daudi cells express glucocorticoid receptors (GR) that mediate Dex-dependent upregulation of BZLF1 mRNA levels. This effect was inhibited by both the glucocorticoid receptor antagonist RU486 and by cycloheximide. The results suggest that GCs, in addition to inducing stress-related immune dysregulation, can mediate latent EBV reactivation through the induction of the BZLF1 gene.
Copyright © 2010 Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflict of Interest Statement: All authors declare that there are no conflicts of interest.
Figures
References
-
- Bauer G. Induction of Epstein-Barr virus early antigens by corticosteroids: Inhibition by TPA and retinoic acid. International Journal of Cancer. 1983;31:291–295. - PubMed
-
- Buchwald D, Umali P, Umali J, Kith P, Pearlman T, Komaroff AL. Chronic fatigue and the chronic fatigue syndrome: prevalence in a Pacific Northwest health care system. Annals of Internal Medicine. 1995;123:81–88. - PubMed
-
- Cacioppo J, Kiecolt-Glaser J, Malarkey W, Laskowski B, Rozlog L, Poehlmann K, Burleson M, Glaser R. Autonomic and glucocorticoid associations with the steady-state expression of latent Epstein-Barr virus. Hormones and Behavior. 2002;42:32–41. - PubMed
-
- Cheung ST, Huang DP, Hui AB, Lo KW, Ko CW, Tsang YS, Wong N, Whitney BM, Lee JC. Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus. International Journal of Cancer. 1999;83:121–126. - PubMed
-
- Chrousos GP, Loriaux DL, Brandon D, Shull J, Renquist D, Hogan W, Tomita M, Lipsett MB. Adaptation of the mineralocorticoid target tissues to the high circulating cortisol and progesterone plasma levels in the squirrel monkey. Endocrinology. 1984;115:25–32. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
